☆ 4.3 Editorial Material

A brief history of NEDA

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2018)

Get Full Text
Add to Collection

Journal

MULTIPLE SCLEROSIS AND RELATED DISORDERS
Volume 20, Issue -, Pages 228-230

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.msard.2017.07.011

Keywords

-

Categories

Clinical Neurology

Funding

  1. Bayer-Schering Healthcare
  2. Biogen-Idec
  3. GW Pharma
  4. Merck
  5. Merck-Serono
  6. Merz
  7. Novartis
  8. Teva
  9. Sanofi-Aventis
  10. Abbvie
  11. Canbex
  12. Eisai
  13. Elan
  14. Fiveprime
  15. Genzyme
  16. Genentech
  17. GSK
  18. Ironwood
  19. Pfizer
  20. Roche
  21. Synthon BV
  22. UCB Pharma
  23. Vertex Pharmaceuticals
  24. Biogen

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.